Filter News
Area of Research
- (-) Functional Materials for Energy (1)
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (8)
- Biological Systems (1)
- Biology and Environment (67)
- Building Technologies (2)
- Clean Energy (128)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (10)
- Electricity and Smart Grid (3)
- Energy Sciences (1)
- Fusion and Fission (7)
- Fusion Energy (2)
- Isotopes (5)
- Materials (47)
- Materials for Computing (10)
- Mathematics (1)
- National Security (22)
- Neutron Science (23)
- Quantum information Science (9)
- Sensors and Controls (1)
- Supercomputing (62)
News Topics
- (-) Biomedical (2)
- (-) Grid (1)
- (-) Machine Learning (1)
- (-) Sustainable Energy (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Artificial Intelligence (1)
- Bioenergy (1)
- Buildings (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (2)
- Environment (2)
- Frontier (1)
- Fusion (8)
- High-Performance Computing (1)
- Isotopes (5)
- Materials (2)
- Materials Science (4)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Simulation (1)
- Space Exploration (5)
- Transformational Challenge Reactor (3)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.